Devita, Hellman, and Rosenberg's Cancer

LWBK1006-Index LWW-Govindan-Review December 19, 2011 19:14

610 Index

Hypertrophic pulmonary

osteoarthropathy, 224

Hypervascular tumors and

ischemia, 175

Hypogammaglobulinemia, 217,

224

Hypoglycemia, 253, 257

Hypothyroidism, 217, 223

Hysterectomy, 144, 147, 320, 327,

330

IA.SeeInvasive cancers (IA)

IBC.SeeInflammatory breast

cancer (IBC)

Ibritumomab, in follicular

lymphoma treatment, 128,

132

IDAC.SeeIntermediate-dose

cytarabine (IDAC)

Idiopathic pneumonitis, 527,

533

Idiopathic pulmonary syndrome,

530, 536

IFN.SeeInterferon (IFN)

Ifosfamide, 131, 372

Ig.SeeImmunoglobulin (Ig)

IGCCCG.SeeInternational Germ

Cell Cancer Collaborative

Group (IGCCCG)

IgG lambda monoclonal protein,

464

IHC.SeeImmunohistochemical

(IHC)

IL-2.SeeInterleukin-2 (IL-2)

Ileal pouch-anal anastomosis

(IPAA), 137, 140

Ileorectal anastomosis (IRA), 137,

140

IL-2 therapy and capillary leak

syndrome, 128, 132–133

Imatinib, 98, 102, 367, 371

in GIST treatment, 261, 265–266

Imatinib mesylate, 15, 19, 27

Immune escape, 108, 112

Immunization, before splenectomy,

545

Immunoediting, 108, 112

Immunoglobulin (Ig), 463

Immunohistochemical (IHC), 475,

479

Immunoperoxidase staining, of

sarcoma, 481

Immunosuppression-related

malignancies, 497–501

Immunosurveillance, 108, 112

Immunotherapy, mechanism for,

105, 110

IMRT.SeeIntensity-modulated

radiation therapy (IMRT)

IMWG.SeeInternational Myeloma

Working Group (IMWG)

Incisional biopsy, 80, 83

Induction chemotherapy, in

SCCHN treatment, 198, 203

Industry funding, impacts of, 582,

585–586

Infections, in cancer patient,

539–549

Infectious Diseases Society of

America (IDSA)

fever defined by, 540, 545

on routine removal of catheters,

546

on severe neutropenia, 545

Inferior vena cava (IVC), 162, 164,

174

Inflammatory breast cancer (IBC),

339, 347

Informed consent, elements of, 581,

585

Inguinal lymph node, 478, 481

INR.SeeInternational normalized

ratio (INR)

Insomnia in dying patients, causes

of, 561, 567

Insulin-like growth factor receptor

1, 6

Insulinoma, 356, 363

Intensity-modulated radiation

therapy (IMRT), 89, 94, 198,

202, 328

Interferon (IFN), 18, 26

in HCC treatment, 50

therapy, effects of, 127, 132

Interim analysis and clinical trial,

188, 194

Interleukin-2 (IL-2), 18, 37, 108,

112

in metastatic renal cell carcinoma

treatment, 80, 83

response rate of, 108, 113

Tax and, 49

Intermediate-dose cytarabine

(IDAC), 441, 447

International Federation of

Obstetrician & Gynecologist

(FIGO), 319, 326

International Germ Cell Cancer

Collaborative Group

(IGCCCG), 227, 302

International Germ Cell Consensus

Classification, 226

International Myeloma Working

Group (IMWG), 472

International normalized ratio

(INR), 440

International Prognostic Index

(IPI), 414, 429

International Prognostic Scoring

System (IPSS), 459, 461

Intra-abdominal leiomyosarcomas,

371

Intracranial pressure, increased,

signs of, 504, 506

Intraepithelial neoplasias, 138

Intraperitoneal chemotherapy, 511,

514

Intravascular catheter-associated

infections, 541, 546

Intravenous acyclovir, in

oropharyngeal HSV, 543,

549

Intravenous hydration, renal

calcium excretion and, 507

Intravenous immunoglobulin, for

parvovirus B19 infection, 544,

549

Invasive cancers (IA), 326

Invasive squamous vulvar cancer

non–HPV-associated, 318, 326

radical vulvectomy with inguinal

lymphadenectomy for, 318,

326

types of, 318, 326

Investigational New Drug (IND)

applications, to FDA, 583,

584, 587, 588

Involuntary active euthanasia, 582,

586

IPAA.SeeIleal pouch-anal

anastomosis (IPAA)

IPI.SeeInternational Prognostic

Index (IPI)

Ipilimumab, 377, 380–381

adverse reaction of, 108, 113

IPSS.SeeInternational Prognostic

Scoring System (IPSS)

IRA.SeeIleorectal anastomosis

(IRA)

Irinotecan, 161, 170, 275

Islet cell tumors, 225

Isocenter, defined, 91

Isochromosome 12p (i[12p]), 226

Isocitrate dehydrogenase 1 (IDH1)

gene, mutations in, 388, 392

Iso-17q, 452, 456

Isotretinoin, 198, 202

Ispaghula, 596

IV bisphosphonate, for malignant

hypercalcemia, 360–361

IVC.SeeInferior vena cava (IVC)

IV hydration, for malignant

hypercalcemia, 360–361

Ivor Lewis esophagectomy, 78, 82

Kaplan-Meier product limit

method, 189